Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

13.85
Delayed Data
As of May 26
 -0.10 / -0.72%
Today’s Change
10.75
Today|||52-Week Range
20.68
-21.75%
Year-to-Date
Top Ranked Income Stocks to Buy for May 24th
May 24 / Zacks.com - Paid Partner Content
Top Ranked Income Stocks to Buy for May 18th
May 18 / Zacks.com - Paid Partner Content
Top Ranked Momentum Stocks to Buy for May 22nd
May 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close13.95
Today’s open14.00
Day’s range13.83 - 14.19
Volume146,880
Average volume (3 months)423,879
Market cap$588.7M
Dividend yield3.61%
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-10.59%
Earnings growth (this year)-15.36%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.64%
P/E ratio19.5
Price/Sales4.17
Price/Book3.53

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.05+0.29%
CALACalithera Bioscience...+0.60+3.92%
ALRPRBAlere Inc-2.48-0.64%
--Quidel Corp+0.36+1.68%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$0.17
Annual revenue (last year)$196.1M
Annual profit (last year)$32.2M
Net profit margin16.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John A. Kraeutler
President &
Chief Commercial Officer
Richard L. Eberly
Corporate headquarters
Cincinnati, Ohio

Forecasts